Overview

Effects of Lanthanum Carbonate on FGF-23 in Subjects With Stage 3 CKD

Status:
Completed
Trial end date:
2012-04-16
Target enrollment:
Participant gender:
Summary
To assess the effects of 12 weeks of treatment with lanthanum carbonate compared with placebo on serum intact Fibroblast Growth Factor 23 (FGF23) levels.
Phase:
Phase 2
Details
Lead Sponsor:
Shire